ArticleActa pharmacologica Sinica2026

Tigecycline suppresses colon cancer stem cells and impairs tumor engraftment by targeting SNAI1-regulated epithelial-mesenchymal transition.

Antonio Jesús Ruiz-Malagón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.